Mimedx (MDXG) Current Taxes (2015 - 2017)

Mimedx's (MDXG) quarterly Current Taxes came in at $2.3 million in Q3 2017, up 383.33% quarter-over-quarter from -$822000.0 in Q2 2017.

Mimedx (MDXG) Current Taxes (2015 - 2017) Analysis & Trends

Mimedx has disclosed Current Taxes across 3 years of filings, most recently posting $2.3 million for Q3 2017.

  • Current Taxes for Q3 2017 came in at $2.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2017 was $2.3 million (changed N/A YoY), and the FY2016 annual result was $5.6 million, up 8474.63% from the prior year.
  • Current Taxes came in at $2.3 million for Q3 2017 at Mimedx, up from -$822000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $7.8 million in Q1 2017 to a low of -$822000.0 in Q2 2017.
  • The 3-year median for Current Taxes is $2.3 million (2017), against an average of $3.0 million.
  • Peak annual rise in Current Taxes reached 8474.63% in 2016, while the deepest fall reached 8474.63% in 2016.
  • Mimedx's Current Taxes stood at -$67000.0 in 2015, then soared by 8474.63% to $5.6 million in 2016, then slumped by 58.49% to $2.3 million in 2017.
  • The last three Current Taxes figures came in at $2.3 million (Q3 2017), -$822000.0 (Q2 2017), and $7.8 million (Q1 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 10,460.56
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 19.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mimedx 546.28 Mn 386.51 Mn 41.62 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 2.33 Mn
Jun 30, 2017 -822,000.00
Mar 31, 2017 7.84 Mn
Dec 31, 2016 5.61 Mn
Dec 31, 2015 -67,000.00